In addition to the Burlingame facility, KindredBio acquired, retrofitted, and commissioned an additional manufacturing facility in Elwood, Kansas. We are uniquely positioned to meet the manufacturing needs of our promising pipeline with combined facilities reaching 180,000 square feet of full-spectrum production, from infancy to commercialization, including labeling and packaging end-to-end processes. KindredBio Clinical and Commercial Manufacturing can support the production of a broad range of biologics and pharmaceuticals. This is done through the use of single-use bioreactor (SUB) up to 2,000L in size and the use of automated vial filling, labeling, and cartoning equipment providing flexibility throughout the process.
KindredBio is one of the few biopharmaceutical manufacturers that can capitalize on its production capacity and maintain a steady revenue stream while ensuring all fulfillment needs are met.